Development

Silicon Valley runs on grey-market peptides

development2026-01-04

Claim

Silicon Valley is increasingly using a grey market of Chinese peptides, including oxytocin marketed as a treatment for autism.

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Knowledge graphopen in browser →

Reported in
Evidence for
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.